Natera IPO gives birth to $180M; FDA gives Galderma a Lyft;

@FierceMedDev: Langer Lab company gets $5M in funding for drug-delivery device. FierceDrugDelivery story | Follow @FierceMedDev

@VarunSaxena2: Cynapsus' sublingual Parkinson's med for 'off' episodes progresses to PhIII. FierceDrugDelivery report | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: Analysts: Roche sale of diabetes diagnostics unit could be a long time coming. Article | Follow @EmilyWFierce

> Galderma's Restylane Lyft was approved by the FDA; it's the first filler specifically for smile lines and to add volume to the cheek area. More

> ProfUSA has raised $11.3 million to back its work on long-term, sensor-based blood glucose monitoring. SEC filing

> Prenatal diagnostics player Natera ($NTRA) has raised $180 million by selling 10 million shares at $18 each, which was the high end of a range that that it had already raised. More

> Spectranetics ($SPNC) subsidiary AngioScore was awarded $20 million by a federal judge in a lawsuit against former board member Eitan Konstantino arguing that he breached his fiduciary duties. More

Biotech News

@FierceBiotech: ICYMI yesterday: Baxalta sets sail with blockbuster ambitions for its growing pipeline. Article | Follow @FierceBiotech

@JohnCFierce: Trending yesterday: Whittled down to biotech size, AstraZeneca's antibiotics crew starts over as Entasis. Article | Follow @JohnCFierce

@DamianFierce: Join us as we search for the Amar'e Stoudemire of immuno-oncology. Listen to FierceBiotech Radio | Follow @DamianFierce

> Gilead takes a $125M FDA shortcut with its latest HIV combo. Report

> Nathalie Adda named Enanta CMO. Chutes and Ladders

> Four years after buyout, Pfizer spins Icagen ion channel platform back out. Article

Pharma News

@FiercePharma: California strikes down exemptions to vaccination requirements for schoolchildren. FierceVaccines story | Follow @FiercePharma

@EricPFierce: Don't miss our July 8 Twitter chat on sustained release with BASF expert Thorsten Cech. Details are here. | Follow @EricPFierce

@CarlyHFierce: Boehringer gets respiratory boost with batch of Spiolto nods in EU. News | Follow @CarlyHFierce

> Scientists dig up new evidence linking GSK's Pandemrix with narcolepsy. Item

> Eylea expected to keep delivering for Regeneron as Praluent starts to step up. Report

Vaccines News

> Study: Flublok is more effective than traditional flu shot. Item

> Actelion pours out $33M to create vaccine startup with Max Planck Society. News

> California strikes down exemptions to vaccination requirements for schoolchildren. Story

> Sanaria raises $48.5M from Equatorial Guinea, oil and gas companies to develop malaria vaccine. Article

> Cancer vaccines field to see sizable growth, report says. More

CRO News

> Quintiles and Quest unveil their clinical trials joint venture. Item

> GVK inks another R&D deal as it moves on from data scandal. Story

> Covance joins trial site group to speed up R&D. News

> PPD strings together a site network for pediatric trials. Article

> BioClinica expands in Europe with a focus on imaging. Report

Pharma Manufacturing News

> Sanofi to improve environmental impact of its manufacturing plants. Item

> Lonza expands New Hampshire plant to make Alexion products. News

> FDA warning letter lays out cross-contamination issues at Canada plant. Story

> Listen up, eardrop makers: FDA says get products approved or face prosecution. Article

> Biogen embarks on major manufacturing expansion. News

Pharma Asia News

> Stormy Australia hearings on transfer pricing by drug firms invoke Sergeant Schultz. Report

> China's Universal prices IPO at $447M as HKEx shows attraction to healthcare. Article

> India's Marksans Pharma buys U.S.-based Time-Cap, a trend in the making? More

> Australia's Prana Biotech touts Imagine PBT2 safety trial outcome in comeback bid. Story

> GSK's ViiV unit to work with China's Desano to make API of Tivicay for access use. Item